304  Convention  for  Revision  of  the  U.  S.  P.  {^/^SST^ 
of  Pharmacy)  ;  D.  W.  Prentiss,  M.D.,  Washington  (National  Medical  College)  ; 
J.  M.  Flint,  Washington  (U.  S.  Navy)  ;  A.  E.  Ebert,  Ph.G.,  Chicago  (American 
Pharmaceutical  Association),  and  Prof.  W.  M.  Searby,  San  Francisco  (Califor- 
nia College  of  Pharmacy). 
For  Secretary,  Hobart  A.  Hare,  M.D.,  Philadelphia  (University  of  Penn- 
sylvania). 
For  Assistant  Secretary,  G.  H.  C.  Klie,  St.  Louis  (Missouri  Pharmaceutical 
Association). 
For  Committee  of  Revisio?i  and  Publication  : 
Prof.  Roberts  Bartholow,  M.D.,  Philadelphia  (Jefferson  Medical  College). 
Prof.  P.  W.  Bedford,  Ph.G.,  New  York  (New  York  College  of  Pharmacy). 
F.  A.  Castle,  M.D.,  New  York  (New  York  Academy  of  Medicine). 
Prof.  C.  A.  Curtman,  M.D.,  St.  Louis  (Missouri  Medical  College). 
N.  S.  Davis,  Jr.,  M.D.,  Chicago. 
Prof.  C.  L.  Diehl,  Ph.M.,  Louisville  (Louisv.  Coll.  Phar.  andKy.  Phar.  Assoc.). 
R.  G.  Eccles,  M.  D.,  Brooklyn  (N.  Y.  State  Pharmac.  Assoc.). 
R.  T.  Edes,  M.D.,  Washington,  D.C.  (Medical  Society  of  the  Dist  of 
Columbia). 
J.  M.  Flint,  M.D.,  Washington,  D.  C.  (U.  S.  Navy). 
John  Godfrey,  M.D.,  Washington,  D.  C.  (U.  S.  Marine  Hospital  Service). 
Prof.  W.  R.  Gregory,  M.D.,  Buffalo  (Buffalo  College  of  Pharmacy). 
C.  S.  N.  Hallberg,  Ph.G.,  Chicago  (Chicago  College  of  Pharmacy). 
Prof.  J.  M.  Maisch,  Phar.D.,  Philadelphia  (Phila.  College  of  Pharmacy). 
Prof.  G.  F.  H.  Markoe,  Ph.G.,  Boston  (Massachusetts  Pharmac.  Assoc.). 
W.  M.  Mew,  M.D.,  Washington,  D.  C.  (U.  S.  Army). 
Chas.  Mohr,  Ph.D.,  Mobile,  Ala.  (Alabama  Pharmaceutical  Association). 
Prof.  O.  Oldberg,  Phar.D.,  Chicago  (Illinois  College  of  Pharmacy). 
Prof.  F.  B.  Power,  Ph.D.,  Madison,  Wis.  (University  of  Wisconsin  School  of 
Pharmacy). 
Prof.  J.  P.  Remington,  Ph.M.,  Philadelphia  (Phila.  Coll.  of  Pharmacy). 
Chas.  Rice,  Ph.D.,  New  York  (New  York  College  of  Pharmacy). 
Prof.  H.  H.  Rusby,  M.D.,  Newark,  N.J.  (New  York  Coll.  of  Pharmacy). 
Prof.  L.  E.  Sayre,  Ph.G.,  Lawrence,  Kan.  (Kansas  Pharmac.  Assoc.). 
Alfred  B.  Taylor,  Ph.M.,  Philadelphia  (American  Pharmac.  Assoc.). 
Prof.  O.  A.  Wall,  Ph.G.,  M.D.,  St.  Louis  (St.  Louis  College  of  Pharmacy). 
Thos.  F.  Wood,  M.D.,  Wilmington,  N.  C.  (North  Carolina  Medical  Society) 
All  these  nominations  were  approved  by  the  Convention,  and  subsequently 
the  President  was  added  to  the  Committee  of  Revision  as  a  member  ex  officio. 
The  Secretary  of  the  Committee  of  Revision  of  1880,  Prof.  Bedford,  read  a 
report  giving  a  resume  of  the  work  done  by  that  Committee  during  the  past  ten 
years.  "Mr.  Doliber,  Treasurer  of  the  same  Committee,  presented  his  report 
showing  that  the  income  of  the  Committee  had  been  from  the  sale  of  about 
17,000  copies  of  the  Pharmacopoeia  $6,797,  and  from  interest  $521.17,  making  a 
total  of  $7,317.17  ;  the  expenses  amounted  to  $4,438.67,  leaving  a  balance  on 
hand  amounting  to  $2,878.50. 
The  reports  were  accepted,  and  the  balance  on  hand  was  directed  to  be  paid 
over  to  the  present  committee. 
The  Convention  then  proceeded  to  the  consideration  of  the  draft  submitted 
